|
|
FDA Grants Additional Indication for Rosuvastatin
|
| Link ID |
655 |
| Title |
FDA Grants Additional Indication for Rosuvastatin |
| Url |
http://www.medscape.com/viewarticle/565651?src=rss |
| Description |
AstraZeneca has gained an additional indication in the US for rosuvastatin, as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol. Doctors will now have the option of prescribing rosuvastatin to those with a 10-year Framingham risk of less than 10%; such patients usually just receive advice on lifestyle interventions. Heartwire |
| Category |
Articles > Cardiology |
| Keywords |
|
| Date |
Nov 12, 2007 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Cardiology |
|
|